S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Bank Accounts: Frozen! (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Bank Accounts: Frozen! (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Bank Accounts: Frozen! (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Bank Accounts: Frozen! (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Bank Accounts: Frozen! (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NASDAQ:CHEK

Check-Cap - CHEK Stock Forecast, Price & News

$1.32
+0.01 (+0.76%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.22
$1.35
50-Day Range
$1.30
$5.78
52-Week Range
$1.22
$9.20
Volume
91,213 shs
Average Volume
N/A
Market Capitalization
$6.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Check-Cap MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.48% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.24mentions of Check-Cap in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.73) to ($2.75) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.31 out of 5 stars


CHEK stock logo

About Check-Cap (NASDAQ:CHEK) Stock

Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.

Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

CHEK Stock News Headlines

Check-Cap (NASDAQ:CHEK) Now Covered by StockNews.com
Check-Cap Issues an Update to Shareholders
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
Why Are Check-Cap Shares Plummeting Today?
Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Up 9.8% in February
Fact-checking Liz Truss at PMQs - BBC
The "King Of Quants" sees 10X potential...
Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...
See More Headlines
Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

CHEK Company Calendar

Last Earnings
11/03/2021
Today
3/25/2023
Next Earnings (Estimated)
4/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CHEK
Employees
65
Year Founded
N/A

Profitability

Net Income
$-17,200,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$10.52 per share

Miscellaneous

Free Float
4,798,000
Market Cap
$6.36 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Alex Ovadia
    Chief Executive Officer
  • Joshua Belkar
    Vice President-Operations
  • Mira Rosenzweig
    Chief Financial Officer
  • Yoav Kimchy
    Chief Technology Officer
  • Boaz Shpigelman
    Vice President-Research & Development













CHEK Stock - Frequently Asked Questions

Should I buy or sell Check-Cap stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Check-Cap in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CHEK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEK, but not buy additional shares or sell existing shares.
View CHEK analyst ratings
or view top-rated stocks.

How have CHEK shares performed in 2023?

Check-Cap's stock was trading at $2.20 at the start of the year. Since then, CHEK shares have decreased by 40.0% and is now trading at $1.32.
View the best growth stocks for 2023 here
.

When is Check-Cap's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 6th 2023.
View our CHEK earnings forecast
.

How were Check-Cap's earnings last quarter?

Check-Cap Ltd. (NASDAQ:CHEK) released its quarterly earnings results on Wednesday, November, 3rd. The medical research company reported ($0.80) earnings per share for the quarter, beating analysts' consensus estimates of ($1.00) by $0.20.

When did Check-Cap's stock split?

Check-Cap's stock reverse split before market open on Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Check-Cap own?
When did Check-Cap IPO?

(CHEK) raised $13 million in an initial public offering (IPO) on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group acted as the underwriters for the IPO and Feltl and Company was co-manager.

What is Check-Cap's stock symbol?

Check-Cap trades on the NASDAQ under the ticker symbol "CHEK."

Who are Check-Cap's major shareholders?

Check-Cap's stock is owned by many different retail and institutional investors. Top institutional investors include Jane Street Group LLC (0.56%).

How do I buy shares of Check-Cap?

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Check-Cap's stock price today?

One share of CHEK stock can currently be purchased for approximately $1.32.

How much money does Check-Cap make?

Check-Cap (NASDAQ:CHEK) has a market capitalization of $6.36 million. The medical research company earns $-17,200,000.00 in net income (profit) each year or ($3.24) on an earnings per share basis.

How can I contact Check-Cap?

Check-Cap's mailing address is 29 ABBA HUSHI AVE. P.O.BOX 1271, ISFIYA L3, 3009000. The official website for the company is www.check-cap.com. The medical research company can be reached via phone at 972546706451, via email at jeremy@lifesciadvisors.com, or via fax at 972-4821-1267.

This page (NASDAQ:CHEK) was last updated on 3/25/2023 by MarketBeat.com Staff